Healthcare provider profile · identity verified

Florie A Gonsch, D.O.

Internal Medicine · PALOS HEIGHTS, IL · NPI 1831144476

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	478	140
Levothyroxine Sodium	Levothyroxine Sodium	420	110
Losartan Potassium	Losartan Potassium	394	112
Amlodipine Besylate	Amlodipine Besylate	391	117
Metoprolol Succinate	Metoprolol Succinate	258	83
Simvastatin	Simvastatin	221	62
Hydrochlorothiazide	Hydrochlorothiazide	212	67
Furosemide	Furosemide	159	52
Alendronate Sodium	Alendronate Sodium	151	43
Lisinopril	Lisinopril	150	44
Metoprolol Tartrate	Metoprolol Tartrate	128	33
Rosuvastatin Calcium	Rosuvastatin Calcium	108	33
Metformin Hcl	Metformin Hcl	99	31
Potassium Chloride	Potassium Chloride	97	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	91	27
Metformin Hcl Er	Metformin Hcl	88	31
Lovastatin	Lovastatin	80	22
Allopurinol	Allopurinol	75	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	72	16
Eliquis	Apixaban	71	18
Pantoprazole Sodium	Pantoprazole Sodium	67	23
Gabapentin	Gabapentin	65	17
Escitalopram Oxalate	Escitalopram Oxalate	58	13
Klor-Con M20	Potassium Chloride	55	13
Fluoxetine Hcl	Fluoxetine Hcl	51	16
Synthroid	Levothyroxine Sodium	51	12
Montelukast Sodium	Montelukast Sodium	50	20
Omeprazole	Omeprazole	48	21
Tramadol Hcl	Tramadol Hcl	47	15
Sertraline Hcl	Sertraline Hcl	45	12
Atenolol	Atenolol	43	12
Albuterol Sulfate Hfa	Albuterol Sulfate	39	21
Donepezil Hcl	Donepezil Hcl	38	suppressed
Celecoxib	Celecoxib	37	11
Fluticasone Propionate	Fluticasone Propionate	37	19
Hydralazine Hcl	Hydralazine Hcl	37	12
Meloxicam	Meloxicam	37	15
Carvedilol	Carvedilol	36	13
Chlorthalidone	Chlorthalidone	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Alprazolam	Alprazolam	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Ramipril	Ramipril	30	suppressed
Glipizide Er	Glipizide	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Glipizide	Glipizide	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Methylprednisolone	Methylprednisolone	21	20
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Ozempic	Semaglutide	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Valsartan	Valsartan	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Trazodone Hcl	Trazodone Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	11
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Lorazepam	Lorazepam	11	suppressed
Prednisone	Prednisone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error